版本:
中国

BRIEF-Axovant Sciences' Q4 loss per share $0.53

June 13 Axovant Sciences Ltd

* Axovant Sciences announces fiscal year-end financial results and corporate updates

* Q4 loss per share $0.53

* Q4 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

* Expects to meet with U.S. Food and Drug Administration to discuss additional studies that could support registration of RVT-103

* Axovant Sciences Ltd says expects to initiate a proof of concept study for RVT-104 in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐